CD301 mediates fusion in IL-4-driven multinucleated giant cell formation

J Cell Sci. 2020 Dec 23;133(24):jcs248864. doi: 10.1242/jcs.248864.

Abstract

Multinucleated giant cells (MGCs) are prominent in foreign body granulomas, infectious and inflammatory processes, and auto-immune, neoplastic and genetic disorders, but the molecular determinants that specify the formation and function of these cells are not defined. Here, using tandem mass tag-mass spectrometry, we identified a differentially upregulated protein, C-type lectin domain family 10 member (herein denoted CD301, also known as CLEC10A), that was strongly upregulated in mouse RAW264.7 macrophages and primary murine macrophages undergoing interleukin (IL-4)-induced MGC formation. CD301+ MGCs were identified in biopsy specimens of human inflammatory lesions. Function-inhibiting CD301 antibodies or CRISPR/Cas9 deletion of the two mouse CD301 genes (Mgl1 and Mgl2) inhibited IL-4-induced binding of N-acetylgalactosamine-coated beads by 4-fold and reduced MGC formation by 2.3-fold (P<0.05). IL-4-driven fusion and MGC formation were restored by re-expression of CD301 in the knockout cells. We conclude that in monocytes, IL-4 increases CD301 expression, which mediates intercellular adhesion and fusion processes that are required for the formation of MGCs.This article has an associated First Person interview with the first author of the paper.

Keywords: Foreign body giant cells; IL-4; Inflammation; Macrophage; Mass spectrometry; Monocyte.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies
  • Asialoglycoproteins*
  • Cell Fusion*
  • Giant Cells*
  • Interleukin-4* / genetics
  • Lectins, C-Type*
  • Macrophages
  • Membrane Proteins*
  • Mice
  • Monocytes*

Substances

  • Antibodies
  • Asialoglycoproteins
  • Clec10a protein, mouse
  • Lectins, C-Type
  • Membrane Proteins
  • Interleukin-4

Grants and funding